---
title: "Xtandi (enzalutamide) in castration-resistant prostate cancer: Dosing and administration questions"
description: "Dosing and administration questions on Xtandi (enzalutamide) in castration-resistant prostate cancer, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Treatment combinations. Questions: Do patients with CRPC need GnRH therapy with Xtandi? 1 question quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/xtandi--castration-resistant-prostate-cancer/dosing-and-administration"
published: "2026-11-14T00:11:41-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Xtandi (enzalutamide) in castration-resistant prostate cancer: Dosing and administration questions

Manufacturer: Astellas Pharma US, Inc.; Pfizer Inc.  
Prescribing information: [Xtandi](https://www.astellas.us/docs/us/12A005-ENZ-WPI.pdf)

Dosing and administration questions that apply to every indication of Xtandi are on [Xtandi (enzalutamide), all indications: Dosing and administration](https://www.evicenter.com/medical-information/xtandi/dosing-and-administration).

## Treatment combinations

<a id="xtandi-gnrh-therapy"></a>

### Do patients with CRPC need GnRH therapy with Xtandi?

> “Patients with CRPC or mCSPC receiving XTANDI should also receive a gonadotropin-releasing hormone (GnRH) analog 
> concurrently or should have had bilateral orchiectomy.”

Source: [XTANDI: Prescribing information, page 2, captured 2026-11-13](https://www.astellas.us/docs/us/12A005-ENZ-WPI.pdf#page=2)

> “Inform patients who have not undergone bilateral orchiectomy and are receiving GnRH therapy that they need to 
> maintain this treatment during the course of treatment with XTANDI.”

Source: [XTANDI: Prescribing information, page 33, captured 2026-11-13](https://www.astellas.us/docs/us/12A005-ENZ-WPI.pdf#page=33)

## Related pages
- [Medical information: Xtandi (enzalutamide): Castration-resistant prostate cancer](https://www.evicenter.com/medical-information/xtandi--castration-resistant-prostate-cancer)
- [Indication](https://www.evicenter.com/medical-information/xtandi--castration-resistant-prostate-cancer/indication)
- [Clinical trials](https://www.evicenter.com/medical-information/xtandi--castration-resistant-prostate-cancer/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/xtandi--castration-resistant-prostate-cancer/safety)
- [Guidelines](https://www.evicenter.com/medical-information/xtandi--castration-resistant-prostate-cancer/guidelines)
